Oxford Financial Group LTD Abb Vie Inc. Transaction History

Oxford Financial Group LTD

$1.58 Billion
Q3 2024

A detailed history of Oxford Financial Group LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Oxford Financial Group LTD holds 5,912 shares of ABBV stock, worth $991,797. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,912

Previous 6,915 14.5%

Holding current value

$991,797

Previous $1.19 Million 1.6%

% of portfolio

0.07%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $164,331 - $199,927	-1,003 Reduced 14.5%	5,912 $1.17 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $203,858 - $238,060	1,317 Added 23.53%	6,915 $1.19 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $28,128 - $32,049	176 Added 3.25%	5,598 $1.02 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $24,080 - $27,119	175 Added 3.34%	5,422 $840,000
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $39,809 - $46,085	-298 Reduced 5.37%	5,247 $782,000
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $353,669 - $440,118	2,669 Added 92.8%	5,545 $747,000
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $29,500 - $33,974	204 Added 7.63%	2,876 $458,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $369,564 - $443,204	2,672 New	2,672 $432,000
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $13,211 - $16,796	96 Added 3.99%	2,505 $384,000
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $4,091 - $5,076	-31 Reduced 1.27%	2,409 $391,000
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $19,229 - $24,331	179 Added 7.92%	2,440 $330,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $207,054 - $235,037	-1,946 Reduced 46.26%	2,261 $244,000
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $95,741 - $106,661	-910 Reduced 17.78%	4,207 $474,000
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $17,186 - $18,920	-168 Reduced 3.18%	5,117 $554,000
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $12,314 - $16,626	153 Added 2.98%	5,285 $566,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $2,147 - $2,520	25 Added 0.49%	5,132 $450,000
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $953 - $1,276	-13 Reduced 0.25%	5,107 $501,000
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $330,240 - $500,684	5,120 New	5,120 $390,000

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oxford Financial Group LTD with notifications on news.

Account

Oxford Financial Group LTD Abb Vie Inc. Transaction History